Plasmodium vivax is the second most prevalent cause of malaria worldwide and the leading
cause of malaria outside of Africa. Although infections are seldom fatal clinical disease can …

Important strides have been made within the past decade toward malaria elimination in
many regions, and with this progress, the feasibility of eradication is once again under …

Malaria in sub-Saharan Africa has historically been almost exclusively attributed to
Plasmodium falciparum (Pf). Current diagnostic and surveillance systems in much of sub …

Zanzibar has made significant progress toward malaria elimination, but recent stagnation
requires novel approaches. We developed a highly multiplexed droplet digital PCR (ddPCR) …

Background Primaquine is the only licensed drug for eradicating Plasmodium vivax
hypnozoites and, therefore, preventing relapses of vivax malaria. It is a vital component of …

Kalimantan is a part of Indonesia, which occupies the southern three-quarters of the island
of Borneo, sharing a border with the Malaysian states of Sabah and Sarawak. Although most …

Abstract The Asia–Pacific region faces formidable challenges in achieving malaria
elimination by the proposed target in 2030. Molecular surveillance of Plasmodium parasites …

This paper summarizes our current understanding of the biology of Plasmodium vivax, how it
differs from Plasmodium falciparum, and how these differences explain the need for P. vivax …

Ethiopia is one of the few African countries where Plasmodium vivax is co-endemic with P.
falciparum. Malaria transmission is seasonal and transmission intensity varies mainly by …

Malaysia has a national goal to eliminate malaria by 2020. Understanding the genetic
diversity of malaria parasites in residual transmission foci can provide invaluable information …